Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?
作者信息
Pelliccia Francesco, Niccoli Giampaolo
机构信息
Department of Cardiovascular Sciences, Sapienza University, Rome, Italy.
Department of Cardiology, University of Parma, Parma, Italy.
出版信息
EuroIntervention. 2022 Aug 19;18(6):452-455. doi: 10.4244/EIJ-D-22-00250.
Abstract
摘要
相似文献
1
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?在直接经皮冠状动脉介入治疗中采用低剂量纤维蛋白溶解疗法预防无复流现象：以退为进？
EuroIntervention. 2022 Aug 19;18(6):452-455. doi: 10.4244/EIJ-D-22-00250.
2
The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时血清类风湿因子水平与无复流现象的关系
J Clin Lab Anal. 2018 Nov;32(9):e22598. doi: 10.1002/jcla.22598. Epub 2018 Jun 26.
3
Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死无复流现象的预测因素。
Ann Cardiol Angeiol (Paris). 2021 Jun;70(3):136-142. doi: 10.1016/j.ancard.2021.04.004. Epub 2021 May 4.
4
Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者入院时单核细胞计数与直接经皮冠状动脉介入治疗后血管造影无复流的相关性。
Kardiol Pol. 2016;74(10):1160-1166. doi: 10.5603/KP.a2016.0065. Epub 2016 May 10.
5
A Possible Marker for No-Reflow in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: Serum Endocan.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流的一种可能标志物：血清内脂素。
Angiology. 2021 Jul;72(6):591-592. doi: 10.1177/0003319721991419. Epub 2021 Feb 2.
6
Response to the letter regarding the article "Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention".关于文章《入院时红细胞分布宽度-血小板比值对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者无复流现象的预测价值》的信件回复
Cardiol J. 2016;23(5):589-590. doi: 10.5603/CJ.2016.0083.
7
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.纤维蛋白原与白蛋白比值对预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流及短期预后的价值
Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16.
8
Impact of D-dimer levels on no-reflow phenomenon following percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis.D - 二聚体水平对ST段抬高型心肌梗死经皮冠状动脉介入治疗后无复流现象的影响：一项荟萃分析
Acta Cardiol. 2023 Oct;78(8):970-973. doi: 10.1080/00015385.2022.2097346. Epub 2022 Jul 5.
9
Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.总缺血时间对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流现象的影响。
Anatol J Cardiol. 2022 May;26(5):382-387. doi: 10.5152/AnatolJCardiol.2021.846.
10
Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.应激性高血糖对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流现象的影响。
Glob Heart. 2022 Mar 29;17(1):23. doi: 10.5334/gh.1111. eCollection 2022.
引用本文的文献
1
Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时的冠状动脉内溶栓治疗：一项随机对照试验的更新荟萃分析。
Cardiovasc Drugs Ther. 2024 Apr;38(2):335-346. doi: 10.1007/s10557-022-07402-3. Epub 2022 Nov 8.
本文引用的文献
1
Intracoronary Thrombolysis in Patients With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.冠状动脉内溶栓治疗 ST 段抬高型心肌梗死患者：随机对照试验的荟萃分析。
Angiology. 2021 Aug;72(7):679-686. doi: 10.1177/0003319721995039. Epub 2021 Feb 12.
2
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.在直接经皮冠状动脉介入治疗期间接受低剂量冠状动脉内溶栓治疗的ST段抬高型心肌梗死患者的长期预后：溶解试验的5年结果
J Thromb Thrombolysis. 2021 Jan;51(1):212-216. doi: 10.1007/s11239-020-02157-w.
3
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.根据缺血时间进行的直接经皮冠状动脉介入治疗中的低剂量阿替普酶。
J Am Coll Cardiol. 2020 Mar 31;75(12):1406-1421. doi: 10.1016/j.jacc.2020.01.041.
4
Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden.冠状动脉内注射尿激酶原治疗高血栓负荷患者的安全性和有效性。
Coron Artery Dis. 2020 Sep;31(6):493-499. doi: 10.1097/MCA.0000000000000853.
5
Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).在 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时应用低剂量冠状动脉内替奈普酶的可行性和安全性（ICE-TIMI 49 研究）。
Am J Cardiol. 2020 Feb 15;125(4):485-490. doi: 10.1016/j.amjcard.2019.11.018. Epub 2019 Nov 20.
6
Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.经导管冠状动脉内溶栓治疗与标准血栓抽吸术治疗 ST 段抬高型心肌梗死患者心肌微循环灌注的比较。
Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):839-845. doi: 10.1002/ccd.28112. Epub 2019 Feb 17.
7
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.急性心肌梗死后直接经皮冠状动脉介入治疗中冠状动脉内应用小剂量尿激酶原对微血 管阻塞的影响：一项随机临床试验。
JAMA. 2019 Jan 1;321(1):56-68. doi: 10.1001/jama.2018.19802.
8
A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗期间使用普洛激酶的随机研究。
J Interv Cardiol. 2018 Apr;31(2):136-143. doi: 10.1111/joic.12461. Epub 2017 Nov 23.
9
Coronary microvascular obstruction in acute myocardial infarction.急性心肌梗死中的冠状动脉微血管阻塞。
Eur Heart J. 2016 Apr 1;37(13):1024-33. doi: 10.1093/eurheartj/ehv484. Epub 2015 Sep 12.
10
Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function.在直接经皮冠状动脉介入治疗后立即冠状动脉内注射链激酶对长期左心室梗死面积、容积及功能的影响。
J Am Coll Cardiol. 2009 Sep 15;54(12):1065-71. doi: 10.1016/j.jacc.2009.04.083.
Zotero 插件